AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 8 added, 4 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 30- Open
- $83.56
- 52-wk high
- $130.09
- High
- $85.69
- 52-wk low
- $82.17
- Low
- $82.17
- Prev close
- $85.04
- Mkt cap
- $56.24B
- P/E
- 14.8x
- Volume
- 7.74M
- Fwd P/E
- 13.0x
- Beta
- 1.20
- Div yield
- 1.85%
- P/S
- 1.5x
- P/B
- 2.4x
- Profit margin
- +9.9%
- Op margin
- +19.0%
- ROE
- +15.8%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CRH filings
Are insiders buying or selling CRH PLC (CRH) stock?
Neither. CRH PLC (CRH) insiders filed no open-market purchases or sales in the 90 days to Oct 1, 2026, according to SEC Form 4 filings.
Which members of Congress have traded CRH recently?
None. No member of Congress disclosed a CRH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CRH smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- DC
Durable Capital
$129.8M
added
Sells/Trims (2)
- BA
Balyasny
$211.3M
trimmed
- SC
Schonfeld
$73.9M
trimmed
What insiders are doing
Sells (1)
- OP
Oriordain Padraig
$156K
sold
How top traders are positioned
No tracked top-trader positions in CRH right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 12.8% above what analysts expected.
Earnings per share
$1.96 expected
Revenue
No comparable estimate
Reports Nov 4, 2026, in 34 days
Estimates as of Sep 30, 2026
EPS expected
$2.08 to $2.33
Revenue expected
10 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $11.07B | $28.74B | $7.37B | $10.78B |
| Cost of what it sold | $6.76B | $18.64B | $5.33B | $6.48B |
| Gross profit | $4.31B | $10.09B | $2.04B | $4.29B |
| What it spent | ||||
| Sales and admin | $2.34B | $1.72B | $2.06B | $2.27B |
| Other operating costs | -$110.0M | $4.68B | $26.0M | — |
| Total operating expenses | $2.23B | $6.40B | $2.08B | $2.27B |
| What was left | ||||
| Operating profit | $2.08B | $3.69B | -$38.0M | $2.08B |
| Interest on debt | $209.0M | $518.7M | $203.0M | $220.0M |
| Profit before tax | $1.92B | $3.33B | -$224.0M | $2.16B |
| Tax | $428.0M | $678.2M | -$55.0M | $661.0M |
| Net profit | $1.50B | $2.61B | -$180.0M | $1.49B |
| EBITDA | $2.85B | $5.36B | $542.0M | $2.93B |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is mixed
Andra AP fonden Invests $2.22 Million in Crh Plc $CRH
BullishSep 24CRH stock hits 52-week low at 83.65 USD
Leans bearishSep 24QRG Capital Management Inc. Buys 14,091 Shares of Crh Plc $CRH
Leans bullishSep 24Analysts Offer Insights on Materials Companies: Avino Silver & Gold (ASM) and CRH plc (CRH)
BullishSep 23CRH Falls as Weak Construction Sentiment and Deal-Related Concerns Weigh on Shares
Leans bearishSep 23CRH (NYSE:CRH) Reaches New 52-Week Low Following Analyst Downgrade
Leans bearishSep 23CRH stock gains as UBS cuts its price target
NeutralSep 23UBS lowers CRH stock price target to $135 on valuation concerns
NeutralSep 22